Benefiting From the...
Health Care: Drugs
Shire PLC (SHPGY: NASDAQ)
$90.23 1.38 | 1.55%
07/19/12 - 04:00 PM ET
Latest Dividend:0.38
Latest Dividend Yield:0.53%
Dividend Ex-Date:03/07/12
Price Earnings Ratio:18.42
Price Earnings Comparisons:
| SHPGY | Sector Avg. | S&P 500 |
|---|---|---|
| 18.42 | 18.40 | 17.70 |
Price Performance History (% change):
| 3 Mo | 1 Yr | 3 Yr |
|---|---|---|
| -7.79 | -10.01 | 112.84 |
| GROWTH | 12 Mo | 3 Yr | CAGR |
|---|---|---|---|
| Revenue | 22.80 | 0.41 | 0.12 |
| Net Income | 47.10 | 3.98 | 0.70 |
| EPS | 43.30 | 4.48 | 0.75 |
Earnings for SHPGY:
| EBITDA | 1.45B |
| REVENUE | 4.26B |
Average Earnings Estimates
| Qtr (06/12) | Qtr (09/12) | FY (12/12) | FY (12/13) | |
|---|---|---|---|---|
| Average Estimate | $1.53 | $1.45 | $6.00 | $6.70 |
| Number of Analysts | 15 | 15 | 16 | 17 |
| High Estimate | $1.70 | $1.70 | $6.60 | $7.69 |
| Low Estimate | $1.48 | $1.29 | $5.62 | $5.91 |
| Prior Year | $1.33 | $1.29 | $5.34 | $6.00 |
| Growth Rate (Year over Year) | 14.99% | 12.71% | 12.38% | 11.69% |
Portfolios with SHPGY
- Portfolio NameUser Type
- ContributorRocket Stocks for the Week ...
- Contributor10 Pharmaceutical Stocks Wi...
- Contributor10 Biotech Stocks Facing FD...
- UserPART 4 JPMorgan 28th Annual...
- UserDartrx Portfolio 1
- ContributorBarron's 2009 Roundtable Pi...
- UserPART 4 JPMorgan 27th Annual...
- UserBarron's Summary 6-14-2008
- UserBarron's Research Reports 5...
- UserWirth Risk
Latest SHPGY Headlines from TheStreet
- Shire PLC (SHPGY): Today's Featured Drugs Loser 07.03.12 | 05:07 pm
- Shire PLC (SHPGY): Today's Featured Health Care Winner 05.11.12 | 04:05 pm
- Shire's CEO Discusses Q1 2012 Results - Earnings Call Transcript 04.26.12 | 07:04 pm
- Shire PLC (SHPGY): Today's Featured Health Care Winner 04.26.12 | 05:04 pm
- Shire Stock To Go Ex-dividend Tomorrow (SHPGY) 03.06.12 | 08:03 am
- Five Reasons Chelsea Therapeutics' Northera Will Get FDA Approval 02.27.12 | 07:02 am
- Shire Stock Hits New 52-Week High (SHPGY) 02.13.12 | 08:02 am
- SHPGY: Trading Along the Flatline 11.28.11 | 11:11 am
- Shire Plc's CEO Discusses Q3 2011 Results - Earnings Call Transcript 10.28.11 | 04:10 pm
- Shire Stock To Go Ex-dividend Tomorrow (SHPGY) 09.06.11 | 09:09 am
Press Releases for SHPGY
- Shire Changes Its NASDAQ Ticker Symbol To SHPG - PR Newswire 07.09.12 | 11:07 am
- Shire's VPRIV® (velaglucerase Alfa For Injection) Shows Significant Improvement In Gaucher-Related Bone Disease - PR Newswire 06.28.12 | 06:06 am
- Shire Announces That The US Food And Drug Administration Has Responded To Its Citizen Petition For Adderall XR And Has Approved One Abbreviated New Drug Application For Generic Adderall XR - PR Newswire 06.23.12 | 10:06 am
- Shire's Advanced BioHealing Commits To Developing Regenerative Medicine Campus In San Diego - PR Newswire 06.11.12 | 08:06 am
- Shire Facebook Page Increases Awareness Of Hereditary Angioedema (HAE) In Support Of First HAE Awareness Day May 16th - PR Newswire 05.14.12 | 01:05 pm
- Shire To Present Scientific Data Across Range Of Psychiatric Disorders At American Psychiatric Association Annual Meeting May 5-9 - PR Newswire 05.04.12 | 09:05 am
- Shire Plc: First Quarter 2012 Results Date Notification - April 26, 2012 - PR Newswire 04.12.12 | 11:04 am
- Shire Adds New Technology Platform And Phase 2 Product Candidate To Its Regenerative Medicine Business - PR Newswire 04.12.12 | 09:04 am
- Shire Announces Top-line Results Of The PREVENT2 Trial - PR Newswire 03.30.12 | 07:03 am
- Shire Reaffirms Support Of Patients Requiring Midodrine HCl; Advances FDA Agreed Upon Clinical Trials - PR Newswire 03.29.12 | 04:03 pm
Partner Headlines for SHPGY
- DJIA Week in Review: Boeing's New Plane Takes Off, GE Climbs 5.2% - Wall St. Cheat Sheet 07.01.12 | 09:07 am
- Verizon DOUBTS on Galaxy S III DELAY and 4 Dow Players Making Moves - Wall St. Cheat Sheet 06.28.12 | 02:06 am
- Benzinga's Upgrade Summary for June 26, 2012 - Benzinga 06.26.12 | 01:06 pm
- Teva Jumps, But Still Must Repair Its Chart Further - Investor's Business Daily 06.25.12 | 05:06 pm
- Stocks Edge Off Session Lows; Teva, Anheuser Busch Climb - Investor's Business Daily 06.25.12 | 03:06 pm
- Stocks Near Lows In Afternoon; Drugmaker Shire Drops - Investor's Business Daily 06.25.12 | 01:06 pm
- Zillow Shares Will CONTINUE Climb and 4 More Fresh Stock Insights - Wall St. Cheat Sheet 06.25.12 | 12:06 pm
- Merck's Osteoporosis Drug Receives INCREASED Attention and 4 More HOT Stock Insights - Wall St. Cheat Sheet 06.25.12 | 12:06 pm
- Generic Adderall XR APPROVAL Means PRESSURE for Shire and 4 More Stock Insights - Wall St. Cheat Sheet 06.25.12 | 12:06 pm
- Augme Technologies Patent Portfolio GROWS and 4 More Fresh Equity Insights - Wall St. Cheat Sheet 06.25.12 | 11:06 am
